We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,477 results
  1. Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan

    Background

    Financial interactions between pharmaceutical companies and physicians lead to conflicts of interest. This study examines the extent and...

    Anju Murayama, Yuki Senoo in BMC Medical Ethics
    Article Open access 20 February 2024
  2. Animals in Research in the Pharmaceutical Industry

    Since early Greek times, animals have provided knowledge critical to understanding human anatomy, physiology, disease injuries, development of...
    Chapter 2023
  3. Cure or Sell: How Do Pharmaceutical Industry Marketers Combine Their Dual Mission? An Approach Using Moral Dissonance

    Pharmaceutical industry marketers are confronted with specific ethical issues linked to the tension between the economic interest being pursued and...

    Bénédicte Bourcier-Béquaert, Loréa Baïada-Hirèche, Anne Sachet-Milliat in Journal of Business Ethics
    Article 29 October 2020
  4. Transparency or restricting gifts? Polish medical students’ opinions about regulating relationships with pharmaceutical sales representatives

    Relationships between physicians and pharmaceutical sales representatives (PSRs) often create conflicts of interest, not least because of the various...

    Marta Makowska, Emilia Kaczmarek, Marcin Rodzinka in Monash Bioethics Review
    Article Open access 07 June 2021
  5. Data privacy protection in scientific publications: process implementation at a pharmaceutical company

    Background

    Sharing anonymized/de-identified clinical trial data and publishing research outcomes in scientific journals, or presenting them at...

    Friedrich Maritsch, Ingeborg Cil, ... Borislava G. Pavlova in BMC Medical Ethics
    Article Open access 25 June 2022
  6. Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?

    Background

    Patient skepticism concerning medical innovations can have major consequences for current public health and may threaten future progress,...

    Laurie Pahus, Carey Meredith Suehs, ... Nicolas Molinari in BMC Medical Ethics
    Article Open access 13 August 2020
  7. Patient Advocacy Organizations and Conflicts of Interest in Research

    Patient advocacy organizations are non-profit groups with important roles in advocacy for patient interests. Many patient organizations are also...
    Chapter 2023
  8. Considerations for applying bioethics norms to a biopharmaceutical industry setting

    Background

    The biopharmaceutical industry operates at the intersection of life sciences, clinical research, clinical care, public health, and...

    Luann E. Van Campen, Tatjana Poplazarova, ... Wendell Fortson in BMC Medical Ethics
    Article Open access 25 March 2021
  9. Ethical and regulatory implications of the COVID-19 pandemic for the medical devices industry and its representatives

    The development and deployment of medical devices, along with most areas of healthcare, has been significantly impacted by the COVID-19 pandemic....

    Brette Blakely, Wendy Rogers, ... Guy Maddern in BMC Medical Ethics
    Article Open access 23 March 2022
  10. Nootropics in the Era of Affective Capitalism: Drug Consumption and Discourse Effects

    This chapter discusses the transmutation of meaning from psychotropic to nootropic (drugs for cognitive enhancement) as a constituent element of the...
    Fabíola Stolf Brzozowski, Marcia da Silva Mazon in Latin American Interdisciplinary Perspectives on Bioethics and Disabilities
    Chapter 2023
  11. On the Normative Foundations of Pharmaceutical Regulation

    I argue that behind the 1962 Food and Drug Administration Act we find a combination of two normative principles: a liberal argument for the...
    Chapter 2020
  12. Managerial Discretion, Market Failure and Democracy

    Managers often have discretion in interpreting their ethical requirements, and they should seek democratic guidance in doing so. The undemocratic...

    Michael Bennett in Journal of Business Ethics
    Article Open access 30 June 2022
  13. Recent efforts to elucidate the scientific validity of animal-based drug tests by the pharmaceutical industry, pro-testing lobby groups, and animal welfare organisations

    Background

    Even after several decades of human drug development, there remains an absence of published, substantial, comprehensive data to validate...

    Jarrod Bailey, Michael Balls in BMC Medical Ethics
    Article Open access 01 March 2019
  14. Participants’ awareness of ethical compliance, safety and protection during participation in pharmaceutical industry clinical trials: a controlled survey

    Background

    The rapid increase of industry-sponsored clinical research towards develo** countries has led to potentially complex ethical issues to...

    Gerardo González-Saldivar, René Rodríguez-Gutiérrez, ... José Gerardo González-González in BMC Medical Ethics
    Article Open access 08 January 2019
  15. Professional Ethics, Professionalization, and Regulation of Pharmaceutical Sales Representatives: Analyzing the Costa Rican Case

    The purpose of this essay is to present an argument in favor of a strong state regulation of sales representatives working for pharmaceutical...
    Chapter 2020
  16. The Health Impact Fund and the Problem of Corruption in the Global Pharmaceutical Sector

    The goal of this chapter is to examine the Health Impact Fund, a proposal aimed at solving the problem of access to pharmaceuticals for the global...
    Chapter 2020
  17. Justifying a morally permissible breach of contract: kantian ethics, nozickian justice, and vaccine patents

    Although some have argued that COVID-19 vaccine patents are morally justified, a broader argument on the morality of breaching contracts is...

    Luís Cordeiro-Rodrigues in Medicine, Health Care and Philosophy
    Article 21 July 2023
  18. Structural Problems in the Practice of Psychiatric Research

    This chapter examines various structural and institutional loop-holes and market incentives that allow pharmaceutical companies to maximize profits...
    Chapter 2023
  19. Environmental risk and market approval for human pharmaceuticals

    This paper contributes to the growing discussion about how to mitigate pharmaceutical pollution, which is a threat to human, animal, and...

    Davide Fumagalli in Monash Bioethics Review
    Article Open access 03 July 2024
  20. Should infectious disease modelling research be subject to ethics review?

    Should research projects involving epidemiological modelling be subject to ethical scrutiny and peer review prior to publication? Mathematical...

    Article Open access 04 August 2023
Did you find what you were looking for? Share feedback.